Cargando…

Early discharge as a mediator of greater ICU‐level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report

Previous data suggest that patients enrolled on clinical trials for treatment of cancer have better overall survival than patients who do not enroll; however, short‐term outcomes relative to trial enrollment and corresponding mediators have not been assessed. A cohort of pediatric patients with newl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Getz, Kelly D., Miller, Tamara P., Seif, Alix E., Li, Yimei, Huang, Yuan‐Shung, Alonzo, Todd, Gerbing, Robert, Sung, Lillian, Hall, Matthew, Bagatell, Rochelle, Gamis, Alan, Fisher, Brian T., Aplenc, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055162/ https://www.ncbi.nlm.nih.gov/pubmed/27474232 http://dx.doi.org/10.1002/cam4.839

Ejemplares similares

Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children’s Oncology Group protocol AAML0531
por: Voigt, Andrew P., et al.
Publicado: (2017)

Merging Children’s Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children’s Oncology Group
por: Li, Yimei, et al.
Publicado: (2015)

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial
por: Rafiee, Roya, et al.
Publicado: (2019)

A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia
por: Getz, Kelly D, et al.
Publicado: (2015)

Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States
por: DiNofia, Amanda M., et al.
Publicado: (2016)

Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia
por: Getz, Kelly D., et al.
Publicado: (2018)

Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology Group
por: Vujkovic, Marijana, et al.
Publicado: (2016)

Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database
por: Citrin, Rebecca, et al.
Publicado: (2017)

Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival
por: Pommert, Lauren, et al.
Publicado: (2022)

Patient-Reported Outcome Coordinator Did Not Improve Quality of Life Assessment Response Rates: A Report from the Children's Oncology Group
por: Johnston, Donna, et al.
Publicado: (2015)

0531. Cumulative effects of negative energy balance on myocardial deformity and diastolic function during the first week of ICU: a pilot study
por: Blizniak, A Gómez, et al.
Publicado: (2014)

Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group
por: Aplenc, Richard, et al.
Publicado: (2020)

P05.31. Development of a manualized protocol of massage therapy for clinical trials in osteoarthritis
por: Ali, A, et al.
Publicado: (2012)

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group
por: Nagarajan, Rajaram, et al.
Publicado: (2019)

Genomes of Geoalkalibacter ferrihydriticus Z-0531(T) and Geoalkalibacter subterraneus Red1(T), Two Haloalkaliphilic Metal-Reducing Deltaproteobacteria
por: Badalamenti, Jonathan P., et al.
Publicado: (2015)

Ethnic Variation of TET2 SNP rs2454206 and Association with Clinical Outcome in Childhood AML: A Report from the Children’s Oncology Group
por: Kutny, Matthew A., et al.
Publicado: (2015)

XC_0531 encodes a c-type cytochrome biogenesis protein and is required for pathogenesis in Xanthomonas campestris pv. campestris
por: Chen, Lei, et al.
Publicado: (2017)

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia
por: Narayanan, P., et al.
Publicado: (2021)

MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
por: Lim, Emilia L., et al.
Publicado: (2017)

P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA
por: Brivio, Erica, et al.
Publicado: (2023)

Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge
por: Zorio, Violette, et al.
Publicado: (2017)

Age or health status: which influences medical insurance enrollment greater?
por: Xu, Wei, et al.
Publicado: (2016)

The impact of eligibility criteria on enrollment in ICU sepsis clinical trials
por: Foster, D, et al.
Publicado: (1999)

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232
por: DiNofia, Amanda M., et al.
Publicado: (2017)

Impact of customised ICU handover protocol on the quality of ICU discharge reports
por: Correia, Paulo César, et al.
Publicado: (2022)

Variation in rates of ICU readmissions and post-ICU in-hospital mortality and their association with ICU discharge practices
por: van Sluisveld, Nelleke, et al.
Publicado: (2017)

Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children’s Oncology Group study
por: Hoff, Fieke W., et al.
Publicado: (2022)

Mews at the time of ICU discharge is associated with outcome
por: Meynaar, IA, et al.
Publicado: (2015)

Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children’s Oncology Group report
por: Long, Xin, et al.
Publicado: (2017)

UNDERSTANDING CAREGIVER PERSPECTIVES ON LIVE DISCHARGE AND RE-ENROLLMENT ONTO HOSPICE CARE
por: Wladkowski, Stephanie P
Publicado: (2022)

The sustainability of premium payment of national health insurance’s self-enrolled members in Jakarta Greater Area
por: Nurhasana, Renny, et al.
Publicado: (2021)

Improvement in functional abilities at ICU discharge is feasible without prolongation of the length of stay ICU
por: Koopmans, Matty, et al.
Publicado: (2016)

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
por: Rasche, Mareike, et al.
Publicado: (2021)

Premature discharge of patients from ICU increases mortality
por: Blunt, MC, et al.
Publicado: (2001)

Assessment of functional capacity after discharge from the ICU
por: Caser, E, et al.
Publicado: (2011)

Quality of life 4 months after ICU discharge
por: Baldwin, F, et al.
Publicado: (2008)

High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
por: Laszlo, George S., et al.
Publicado: (2015)

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
por: Laszlo, George S., et al.
Publicado: (2016)

Greater Well-Being in More Physically Active Cancer Patients Who Are Enrolled in Supportive Care Services
por: Tristão Parra, Maíra, et al.
Publicado: (2020)

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
por: Huang, Benjamin J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3tcou291v7dbevqpdoaolgus6b